Diversity and Divergence in HIV-1 Viral Variants between patients with high CD4+ T Cell Variability and Patients with Rapid CD4+ T Cell Decline Kevin Paiz-Ramirez.

Slides:



Advertisements
Similar presentations
Changes In Protein Sequences Of the HIV-1 gp120 V3 Region In Non-Progressor Types Nicki S.Harmon Samantha M. Hurndon.
Advertisements

Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in HER2- Positive, First-Line Metastatic Breast Cancer (MBC) Baselga.
Genetic Similarities Between HIV-1 Viruses in the Onset of AIDS Isabel Gonzaga BIOL : Bioinformatics Laboratory Loyola Marymount University October.
Personal perspective: an HIV-positive family
Molecular Clock I. Evolutionary rate Xuhua Xia
Journal Club Alcohol and Health: Current Evidence January-February 2006.
Materials and Methods Abstract Conclusions Introduction 1. Korber B, et al. Br Med Bull 2001; 58: Rambaut A, et al. Nat. Rev. Genet. 2004; 5:
Basic Facts on HIV/AIDS By David Schulman. Learning objectives By the end of this presentation you will be able to: Discuss the difference between HIV.
An Introduction to the HIV Problem Space Oakwood University: Faculty Quantitative Institute Aug. 10–12, 2009.
Examination of Amino Acid Differences as a Means of Determining Functional Changes in HIV-1 Protein Sequences Chris Rhodes and Isaiah Castaneda Loyola.
Natural History and Clinical Staging of HIV Training for Medical Officers Day 2 Session 7.
Analysis of HIV Evolution Bobak Seddighzadeh and Kristoffer Chin Department of Biology Loyola Marymount University Bio February 23, 2010.
Clinical Care of HIV, AIDS and Opportunistic Infections
Why study evolution?  Best conceptual framework for understanding origins of biodiversity  Adaptations that allow organisms to exploit their environment.
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
Unconserved Amino Acid Sequences in V3 Domain of gp120 Show No Significant Correlation to Altered Folding and Function Bobak Seddighzadeh Alex George.
Using Molecular Information to Investigate the Evolutionary Origin of the HIV Virus.
STEPHANIE HINTZEN BIOL 471 SIV and HIV: Differences in Diversity and Divergence.
Re evaluating the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi & Ryan Willhite Loyola Marymount University.
A Mutational Investigation of an HIV Patient’s GP120 Glycoprotein and it’s Implications on CD4 Binding Salita Kaistha Usrinus College, Collegeville PA.
Predicting the Onset of AIDS Robert Arnold, Alex Cardenas, Zeb Russo LMU Biology Department 10/5/2011.
Supporting Scientific Collaboration Online SCOPE Workshop at San Diego Supercomputer Center March 19-22, 2008.
Patterns of selection for or against amino acid change among different CD4 T-cell count progressor groups Michael Pina, Salomon Garcia Journal Club Presentation.
Mutations on the V3 loop of gp120 may predict progression to AIDS Derese Getnet, Dr. Rebecca Roberts, Structural Biology, Ursinus College, Collegeville.
Amino Acid Sequences in V3 Loop Conformation Alex Cardenas, Bobby Arnold and Zeb Russo Loyola Marymount University Department of Biology BIO /02/11.
Predicting the Onset of AIDS Robert Arnold, Alex Cardenas, Zeb Russo LMU Biology Department 10/5/2011.
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
Research on killer HIV antibodies provides promising new ideas for vaccine design New discoveries about the immune defenses of rare HIV patients who produce.
Analyzing Differences in Protein Sequences Between Subjects with Varying T Cell Counts J’aime Moehlman Amanda Wavrin Loyola Marymount University March.
Changes In Protein Sequences Of the HIV-1 gp120 V3 Region In Non-Progressor Types Nicki S.Harmon Samantha M. Hurndon LMU Department of Biology BIOL 368.
Evolution of the Functional Profile of HIV-Specific CD8+ T cells in a Cohort of Long Term Nonprogressors M López, N Rallón, A Peris, M Salgado, B Rodés,
Examining the Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano Bioinformatics Laboratory Loyola.
Pp  HIV: human immunodeficiency virus  AIDS (acquired immune deficiency syndrome): weakened immune system caused by the infection of HIV HIV.
V3 Loop Binding to CCR5 and CXCR4 of Rapid and Non Progressor HIV Patients in Baltimore MD BackgroundCCR5 and CXCR4 Receptor Rapid-progressor Patient 10.
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Student Project Showcase – April 2008 Classroom Pearls for Life Sciences and Mathematics Students J. de Varona, E. Demirci, S. Koksal S2 Figure 1: Photo.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
Examining Genetic Similarity and Difference of the Three Progressor Groups at the First and Middle Visits Nicole Anguiano BIOL398: Bioinformatics Laboratory.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Influence of the Timing of Antiretroviral Therapy.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Investigations of HIV-1 Env Evolution Evolutionary Bioinformatics Education: A BioQUEST Curriculum Consortium Approach Grand Valley State University August.
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Journal Club Presentation BIOL368/F16: Bioinformatics Laboratory
Colin Wikholm William Fuchs
Amino Acid Sequences in V3 Loop Conformation
Table 2. Mean intrasubject diversity for the 11 study participants, by genomic region. From: Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects.
The V3 Region Expresses More Diversity in Amino Acid Sequence in AIDS Diagnosed Patients than in Non-Trending and AIDS Progressing Patients HIV Structure.
Do HIV+ Rapid Progressors Show More Divergence than Non-Progressors?
Amino Acid Sequences in V3 Loop Conformation
Predicting the Onset of AIDS
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Investigations of HIV-1 Env Evolution
Loyola Marymount University
LMU Department of Biology
ئەيدىز كېسىلى (AIDS) مەمەتئىمىن دوكتۇر.
Predicting the Onset of AIDS
Loyola Marymount University
Loyola Marymount University
Amino Acid Sequences in V3 Loop Conformation
Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A,
Predicting the Onset of AIDS
Residue Sequence and Structure in the Re evaluation the Categorization of HIV Progression in Subjects Based on CD4 T cell Decline Rates Angela Garibaldi.
Patterns of amino acid usage and its GC-content of synonymous codons in 65 nuclear genomes in this study. Patterns of amino acid usage and its GC-content.
Chloe Jones, Isabel Gonzaga, and Nicole Anguiano
Loyola Marymount University
Presentation transcript:

Diversity and Divergence in HIV-1 Viral Variants between patients with high CD4+ T Cell Variability and Patients with Rapid CD4+ T Cell Decline Kevin Paiz-Ramirez Janelle N. Ruiz Biology Professor Kam D. Dahlquist, Ph.D. Department of Biology Loyola Marymount University March 2nd, 2009

Outline I. HIV-1 Background II. Markham et al. Previous Studies III. Research Questions IV. Results A. Diversity Between Groups B. Divergence Between Groups V. Interpretations between synonymous & non- synonymous Groups VI. Limitations To Results VII. Interpretations In Light of Recent Studies VIII. References

Background HIV-1 Human Immunodeficiency Virus, is categorized into 3 stages Seroconversion ~7-8 weeks Latency ~variable period of years Acquired Immune Deficency Syndrome Center for Disease Control’s Public Health Image Library #10000

Markham, et al. Markham et al. explored analyses of synonymous and non-synonymous differences and rates of divergence to reveal selective heterogeneity as a function of disease progression category We chose to examine if there are differences in HIV-1 diversity or divergence between participants with high CD4 T-Cell variability within the study, between visits as compared to participants with linear progression

Research Question Are their differences in HIV-1 diversity or divergence between participants with high CD4 T cell variability between visits as compared to participants with rapid CD4+ T Cell decline (slope ~ -1)? Linear ProgressorsHigh Variability

How Were Subjects Chosen? Linear Progressors: Patients with rapid CD4+ T Cell Decline

High Variability: Patients with high CD4 T cell variability between visits How Were Subjects Chosen?

High Variability: Patients with high CD4 T cell variability between visits How Were Subjects Chosen?

Low Variability: Patients with low CD4 T cell variability between visits How Were Subjects Chosen?

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

Low Variability DIVERSITY: Comparing Number of Clones for all Visits Across Groups

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

DIVERSITY: Comparing the S Value Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 6 Subject 5 Linear ProgressorsHigh Variability Low Variability Group # S Value

DIVERSITY: Comparing the S Value Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 5 Linear ProgressorsHigh Variability Low Variability Group # S Value P Value: Subject 6

DIVERSITY: Comparing the S Value Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 6 Subject 5 Linear ProgressorsHigh Variability Low Variability Group # S Value P Value:

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

DIVERGENCE: Comparing Theta Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 6 Subject 5 Group # Theta Linear ProgressorsHigh Variability Low Variability

DIVERGENCE: Comparing Theta Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 6 Subject 5 Group # Theta Linear ProgressorsHigh Variability Low Variability P Value:

DIVERGENCE: Comparing Theta Across Groups Subject 4 Subject 10 Subject 12 Subject 8 Subject 6 Subject 5 Group # Theta Linear ProgressorsHigh Variability Low Variability P Value:

Diversity and Divergence Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability

DIVERGENCE: Comparing Min and Max Differences Across Groups SubjectClassification # of Clones (all visits)Min DifferenceMax Difference 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability P Value: >.05

DIVERGENCE: Comparing Min and Max Differences Across Groups SubjectClassification # of Clones (all visits)Min DifferenceMax Difference 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability P Value: >.05

Research Question Are their differences in HIV-1 diversity or divergence between participants with high CD4 T cell variability between visits as compared to participants with rapid CD4+ T Cell decline (slope ~ -1)? Linear ProgressorsHigh Variability

Differences exist in diversity and divergence of HIV-1 variants b/w Groups Linear Progressors show higher diversity HIV-1 variants as shown by higher number of clones and higher S value compared to subjects with High Variability in CD4 count. Linear Progressors show higher divergence in HIV-1 variants as shown by higher value of theta compared to subjects with High Variability in CD4 count. Hypothesis supported?

Limitations to Results Only looked at first 5 visits to maintain consistency and due to limitations of analytical software Issues with Subject 8 versus Subject 6 in high variability group Missing data for subject 4 (visits 5-7) Only one subjects in low variability group; therefore could not run T Tests with this group

Synonymous versus Non-Synonymous mutations Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability P Value: >.05

Synonymous versus Non-Synonymous mutations Between Groups SubjectClassification Number of visits # of Clones (all visits)SThetaMin Difference Max Difference Median dS/dN 4Linear Progressor Linear Progressor High Variability High Variability High Variability Low Variability P Value: >.05

Synonymous versus Non-Synonymous mutations Between Groups Appears to be no significant differences in synonymous versus non-synonymous mutations in HIV-1 variants between linear progressors and high variability group Participants with low variability in CD4 count appear to show selection against Non- synonymous mutations in HIV-1 variants

Templeton, et al. Templeton’s article examined selection of 15 subjects similar to the Markham study, but further investigated a broader range of potential selective contexts. Overall disease progression categories: CD4 and CD8 T- Cell counts Mutations leading to amino acid substitutions were subject to positive selection over a broad range of clinical conditions in nonsyncytium inducing form (NSI) It was determined that the study must be focused in the V3 region

Templeton, et al. The results indicated that the V3 region is subject to selection, but cannot be summarized in a marginal fashion to a single variable such as CD4 counts. Diverse patterns of V3 region evolution depending on rapid and non-progressors. The V3 region is context dependent. Further studies of this region could be explored in the HIV-1 Genome.

References Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, and Yu XF. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc Natl Acad Sci U S A 1998 Oct 13; 95(21) Templeton Alan R, Reichert R, Weisstein A, Xia-Fang Y, Markham RB. Selection in Context: Patterns of Natural Selection in the Glycoprotein 120 Region of Human Immunodeficiency Virus 1 Within Infected Individuals. Genetics Society of America USA 2004, Dec 20: